These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 30903722

  • 21. Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome.
    Kesiraju S, Paritala P, Rao Ch UM, Athmakuri SM, Reddy VS, Sahariah S.
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):9-15. PubMed ID: 24434376
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.
    Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622
    [Abstract] [Full Text] [Related]

  • 24. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M, Leblanc MH, Perrault LP, White M, Doyle D, Beaudoin D, Guertin MC.
    J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
    [Abstract] [Full Text] [Related]

  • 25. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin Induction Study Group.
    N Engl J Med; 2006 Nov 09; 355(19):1967-77. PubMed ID: 17093248
    [Abstract] [Full Text] [Related]

  • 26. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
    Lee H, Lee S, Jeon JS, Kwon SH, Noh H, Han DC, Yun S, Song D.
    Transplant Proc; 2018 Jun 09; 50(5):1285-1288. PubMed ID: 29880348
    [Abstract] [Full Text] [Related]

  • 27. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.
    Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP.
    J Am Soc Nephrol; 2017 Jul 09; 28(7):2188-2200. PubMed ID: 28320767
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 30. Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation.
    Sureshkumar KK, Chopra B.
    Transplant Proc; 2019 Sep 27; 51(6):1796-1800. PubMed ID: 31399165
    [Abstract] [Full Text] [Related]

  • 31. Low Immunologic Risk Living Related Renal Transplant Using Very Low-Dose Antithymocyte Globulin as Induction Therapy: A Single Tertiary Hospital Experience.
    Jalalonmuhali M, Ng KP, Ong CS, Lee YW, Wan Md Adnan WAH, Lim SK.
    Transplant Proc; 2020 Sep 27; 52(6):1709-1714. PubMed ID: 32448669
    [Abstract] [Full Text] [Related]

  • 32. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM, Keating GM.
    Drugs; 2003 Sep 27; 63(24):2803-35. PubMed ID: 14664658
    [Abstract] [Full Text] [Related]

  • 33. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 34. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 35. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
    Kim JM, Jang HR, Kwon CH, Huh WS, Kim GS, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2012 Jan 27; 44(1):167-70. PubMed ID: 22310606
    [Abstract] [Full Text] [Related]

  • 36. Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab.
    Pham C, Kuten SA, Knight RJ, Nguyen DT, Graviss EA, Gaber AO.
    Transpl Infect Dis; 2020 Jun 27; 22(3):e13257. PubMed ID: 32031729
    [Abstract] [Full Text] [Related]

  • 37. Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
    Ghanekar A, Kashfi A, Cattral M, Selzner N, McGilvray I, Selzner M, Renner E, Lilly L, Levy G, Grant D, Greig P.
    Transplant Proc; 2012 Jun 27; 44(5):1351-6. PubMed ID: 22664014
    [Abstract] [Full Text] [Related]

  • 38. Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients.
    Masset C, Kerleau C, Blancho G, Hourmant M, Walencik A, Ville S, Kervella D, Cantarovich D, Houzet A, Giral M, Garandeau C, Dantal J, Nantes DIVAT Consortium.
    Transpl Int; 2023 Jun 27; 36():10816. PubMed ID: 36819125
    [Abstract] [Full Text] [Related]

  • 39. Obesity in renal transplantation: the role of induction therapy on long-term outcomes.
    Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR.
    Transplant Proc; 2011 Mar 27; 43(2):469-71. PubMed ID: 21440736
    [Abstract] [Full Text] [Related]

  • 40. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.
    Clin Transplant; 2011 Mar 27; 25(3):E250-6. PubMed ID: 21231963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.